Effective Bronchodilator Resuscitation of Children in the Emergency Room: Device or Interface?

References

1. 1.↵
   1. Kelly H,
   2. Keim K,
   3. McWilliams B

   . Comparison of two methods of delivering continuously nebulized albuterol. Ann Pharmacother 2003;37(1):23–26.

   OpenUrlAbstract/FREE Full Text
2. 2.
   1. Papo MC,
   2. Frank J,
   3. Thompson AE

   . A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;21(10):1479–1486.

   OpenUrlPubMedWeb of Science
3. 3.
   1. Khine H,
   2. Fuchs SM,
   3. Saville AL

   . Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med 1996;3(11):1019–1024.

   OpenUrlPubMedWeb of Science
4. 4.
   1. Camargo CA Jr.,
   2. Spooner CH,
   3. Rowe BH

   . Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003;(4):CD001115.
5. 5.
   1. Fink J,
   2. Dhand R

   . Bronchodilator resuscitation in the emergency department, part 1: device selection. Respir Care 1999;44(10):1353–1374.

   OpenUrl
6. 6.↵
   1. Reisner C,
   2. Kotch A,
   3. Dworkin G

   . Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized prospective study. Ann Allergy Asthma Immunol 1995;75(1):41–47.

   OpenUrlPubMedWeb of Science
7. 7.↵
   1. Berlinski A,
   2. Willis JR,
   3. Leisenring T

   . In-vitro comparison of 4 large-volume nebulizers in 8 hours of continuous nebulization. Respir Care 2010;55(12):1671–1679.

   OpenUrlPubMed
8. 8.↵
   1. Ari A,
   2. Hess D,
   3. Myers TR,
   4. Rau JL

   . A guide to aerosol delivery devices for respiratory therapists, 2nd edition. Irving, TX: American Association for Respiratory Care; 2009. http://www.aarc.org/education/aerosol_devices/aerosol_delivery_guide2.pdf. Accessed April 12, 2011.
9. 9.↵
   1. Rau JL,
   2. Ari A,
   3. Restrepo RD

   . Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care 2004;49(2):174–179.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Sangwan S,
    2. Condos R,
    3. Smaldone G

    . Lung deposition and respirable mass during wet nebulization. J Aerosol Med 2003;16(4):379–386.

    OpenUrlPubMed
11. 11.↵
    1. Sabato K,
    2. Ward P,
    3. Hawk W,
    4. Gildengorin V,
    5. Asselin JM

    . Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. Respir Care 2011;56(6):761–770.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Benton G,
    2. Thomas RC,
    3. Nickerson BG,
    4. McQuitty JC,
    5. Okikawa J

    . Experience with a metered-dose inhaler with a spacer in the pediatric emergency department. Am J Dis Child 1989;143(6):678–681.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Esposito-Festen JE,
    2. Ates B,
    3. van Vliet FJ,
    4. Verbraak AF,
    5. de Jongste JC,
    6. Tiddens HA

    . Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J Aerosol Med 2004;17(1):1–6.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.
    1. Smaldone GC,
    2. Sangwan S,
    3. Shah A

    . Facemask design, facial deposition, and delivered dose of nebulized aerosols. J Aerosol Med 2007;20(Suppl 1):S66–S75.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.
    1. Rau JL,
    2. Smaldone GC

    . The interface between the device and the patient: masks, mouthpieces, and “others”. Introduction. J Aerosol Med 2007;20(Suppl 1):S1–S2.

    OpenUrlPubMed
16. 16.
    1. Janssens H,
    2. Tiddens H

    . Aerosol therapy: the special needs of young children. Pediatr Respir Rev 2006;7(Suppl 1):S83–S85.

    OpenUrl
17. 17.↵
    1. Janssens HM,
    2. Tiddens HA

    . Facemasks and aerosol delivery by metered dose inhaler-valved holding chamber in young children: a tight seal makes the difference. J Aerosol Med 2007;20(Suppl 1):S59–S63.

    OpenUrlPubMed
18. 18.
    1. Erzinger S,
    2. Schueepp KG,
    3. Brooks-Wildhaber J,
    4. Devadason SG,
    5. Wildhaber JH

    . Facemasks and aerosol delivery in vivo. J Aerosol Med 2007;20(Suppl 1):S78–S83.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.
    1. Restrepo RD,
    2. Dickson SK,
    3. Rau JL,
    4. Gardenhire DS

    . An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir Care 2006;51(1):56–61.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Lin HL,
    2. Restrepo RD,
    3. Gardenhire DS,
    4. Rau JL

    . Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Respir Care 2007;52(8):1021–1026.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Rubin BK

    . Bye-bye, blow-by (editorial). Respir Care 2007;52(8):981.

    OpenUrlFREE Full Text
22. 22.↵
    1. Everard ML

    . Inhaler devices in infants and children: challenges and solutions. J Aerosol Med 2004;17(2):186–195.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Everard ML

    . Aerosol delivery to children. Pediatr Ann 2006;35(9):630–636.

    OpenUrlPubMed
24. 24.↵
    1. Janssens H,
    2. van der Wiel E,
    3. Verbraak A,
    4. de Jongste J,
    5. Merkus P,
    6. Tiddens H

    . Aerosol therapy and the fighting toddler: is administration during sleep an alternative? J Aerosol Med 2003;16(4):395–400.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Ari A,
    2. Harwood R,
    3. Sheard M,
    4. Dailey P,
    5. Fink JB

    . In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatr Pulmonol 2011;[Epub ahead of print]. doi: 10.1002/ppul.21421
26. 26.↵
    1. Bhashyam AR,
    2. Wolf MT,
    3. Marcinkowski AL,
    4. Saville A,
    5. Thomas K,
    6. Carcillo JA,
    7. Corcoran TE

    . Aerosol delivery through nasal cannulas: an in vitro study. J Aerosol Med Pulm Drug Deliv 2008;21(2):181–188.

    OpenUrlPubMed